Interferon regulator factor 1/retinoic inducible gene i (IRF1/RIG-I) axis mediates 25-hydroxycholesterol-induced interleukin-8 production in atherosclerosis

Cardiovascular Research

Volumn 93, Issue 1, 2012, Pages 190-199

  Wang, Feng ^a   Xia, Weiwei ^a   Liu, Feng ^a   Li, Ji ^a   Wang, Guang ^a   Gu, Jun ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

25 Hydroxycholesterol; Atherosclerosis; Inflammation; Interferon regulatory factor 1; Retinoic inducible gene I

Indexed keywords

25 HYDROXYCHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 6; INTERLEUKIN 8; MITOCHONDRIAL ANTIVIRAL SIGNALLING PROTEIN; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RETINOIC ACID INDUCIBLE PROTEIN I; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; ENDOTHELIUM; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BASE SEQUENCE; CHEMOKINE CXCL1; DEAD-BOX RNA HELICASES; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROXYCHOLESTEROLS; INTERFERON REGULATORY FACTOR-1; INTERLEUKIN-8; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84555188580     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr260     Document Type: Article

References (36)

1. Wang SS, Schadt EE, Wang H, Wang X, Ingram-Drake L, Shi W et al. Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circ Res 2007;101:e11-e30. (Pubitemid 47344081)
2. Ferri C, Croce G, Cofini V, De Berardinis G, Grassi D, Casale R et al. C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis. Curr Pharm Des 2007;13:1631-1645. (Pubitemid 46979719)
3. Aukrust P, Yndestad A, Smith C, Ueland T, Gullestad L, Dama°s JK. Chemokines in cardiovascular risk prediction. Thromb Haemost 2007;97:748-754. (Pubitemid 46779960)
4. Erridge C, Webb DJ, Spickett CM. 25-Hydroxycholesterol, 7b-hydroxycholesterol and 7-ketocholesterol upregulate interleukin-8 expression independently of Toll-like receptor 1, 2, 4 or 6 signalling in human macrophages. Free Radic Res 2007;41: 260-266. (Pubitemid 46404468)
5. Suriyaphol P, Fenske D, Zahringer U, Han SR, Bhakdi S, Husmann M. Enzymatically modified nonoxidized low-density lipoprotein induces interleukin-8 in human endothelial cells: role of free fatty acids. Circulation 2002;106:2581-2587. (Pubitemid 35340695)
6. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999;398:718-723.
7. Matsushima K, Baldwin ET, Mukaida N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem Immunol 1992;51:236-265.
8. Yue TL,Wang X, Sung CP, Olson B, McKenna PJ, Gu JL et al. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res 1994;75:1-7.
9. Temaru R, Urakaze M, Satou A, Yamazaki K, Nakamura N, Kobayashi M. High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: possible role of interleukin-8 in diabetic macroangiopathy. Diabetologia 1997;40:610-613. (Pubitemid 27186800)
10. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem 1996;271:8837-8842. (Pubitemid 26123306)
11. Apostolopoulos J, Davenport P, Tipping PG. Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol 1996;16:1007-1012. (Pubitemid 26266900)
12. Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Synergistic proinflammatory effects of the antiviral cytokine interferon-a and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation 2007;116:2043-2052. (Pubitemid 350023750)
13. Erridge C, Webb DJ, Spickett CM. Toll-like receptor 4 signalling is neither sufficient nor required for oxidised phospholipid mediated induction of interleukin-8 expression. Atherosclerosis 2007;193:77-85. (Pubitemid 46776713)
14. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K et al. Cell typespecific involvement of RIG-I in antiviral response. Immunity 2005;23:19-28. (Pubitemid 41019654)
15. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus-triggered IFN-b signaling. Mol Cell 2005;19:727-740. (Pubitemid 41316668)
16. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kB and IRF 3. Cell 2005;122: 669-682. (Pubitemid 41242633)
17. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005;437:1167-1172. (Pubitemid 41509355)
18. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 2005;6: 981-988. (Pubitemid 41486182)
19. Wang J, Wu S, Jin X, Li M, Chen S, Teeling JL et al. Retinoic acid-inducible gene-I mediates late phase induction of TNF-a by lipopolysaccharide. J Immunol 2008;180: 8011-8019.
20. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
21. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997;35:2-3.
22. Zcharia E, Zilka R, Yaar A, Yacoby-Zeevi O, Zetser A, Metzger S et al. Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J 2005;19:211-221. (Pubitemid 40192578)
23. Zhu YM, Bradbury DA, Pang L, Knox AJ. Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoiddependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoid-independent activation of NF-kB. J Biol Chem 2003;278:29366-29375. (Pubitemid 36935854)
24. Wolfrum S, Teupser D, Tan M, Chen KY, Breslow JL. The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kB target genes. Proc Natl Acad Sci USA 2007;104:18601-18606. (Pubitemid 350210743)
25. Matsumiya T, Prescott SM, Stafforini DM. IFN-1 mediates TNF-a-induced STAT1 phosphorylation and induction of retinoic acid-inducible gene-I in human cervical cancer cells. J Immunol 2007;179:4542-4549.
26. Imaizumi T, Hatakeyama M, Yamashita K, Yoshida H, Ishikawa A, Taima K et al. Interferon-g induces retinoic acid-inducible gene-I in endothelial cells. Endothelium 2004;11:169-173. (Pubitemid 39386586)
27. Hodis HN, Crawford DW, Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 1991;89:117-126.
28. Shibata N, Glass CK. Macrophages, oxysterols and atherosclerosis. Circ J 2010;74: 2045-2051.
29. Hsu MH,Wang M, Browning DD, Mukaida N, Ye RD. NF-kB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cells. Blood 1999;93: 3241-3249. (Pubitemid 29220890)
30. Lee SW, Han SI, Kim HH, Lee ZH. TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kB. J Biochem Mol Biol 2002;35: 371-376. (Pubitemid 34868675)
31. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K. The kinase TAK1 can activate the NIK-IkB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999;398:252-256.
32. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKKactivation byBCL10 andMALT1 inTlymphocytes.Mol Cell 2004;14:289-301. (Pubitemid 38591401)
33. Porreca E, Sergi R, Baccante G, Reale M, Orsini L, Febbo CD et al. Peripheral blood mononuclear cell production of interleukin-8 and IL-8-dependent neutrophil function in hypercholesterolemic patients. Atherosclerosis 1999;146:345-350. (Pubitemid 29418066)
34. Curtiss LK, Tobias PS. The toll of Toll-like receptors, especially Toll-like receptor 2, on murine atherosclerosis. Curr Drug Targets 2007;8:1230-1238.
35. Bachmaier K, Neu N, Pummerer C, Duncan GS, Mak TW, Matsuyama T et al. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 1997;96:585-591. (Pubitemid 27329438)
36. Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol 2008;9:378-387. (Pubitemid 351405107)